176 related articles for article (PubMed ID: 33155181)
1. Thyroid nodules in xeroderma pigmentosum patients: a feature of premature aging.
Kouatcheu SD; Marko J; Tamura D; Khan SG; Lee CR; DiGiovanna JJ; Kraemer KH
J Endocrinol Invest; 2021 Jul; 44(7):1475-1482. PubMed ID: 33155181
[TBL] [Abstract][Full Text] [Related]
2. Reproductive Health in Xeroderma Pigmentosum: Features of Premature Aging.
Merideth M; Tamura D; Angra D; Khan SG; Ferrell J; Goldstein AM; DiGiovanna JJ; Kraemer KH
Obstet Gynecol; 2019 Oct; 134(4):814-819. PubMed ID: 31503159
[TBL] [Abstract][Full Text] [Related]
3. Xeroderma Pigmentosum: A Model for Human Premature Aging.
Rizza ERH; DiGiovanna JJ; Khan SG; Tamura D; Jeskey JD; Kraemer KH
J Invest Dermatol; 2021 Apr; 141(4S):976-984. PubMed ID: 33436302
[TBL] [Abstract][Full Text] [Related]
4. Cancer and neurologic degeneration in xeroderma pigmentosum: long term follow-up characterises the role of DNA repair.
Bradford PT; Goldstein AM; Tamura D; Khan SG; Ueda T; Boyle J; Oh KS; Imoto K; Inui H; Moriwaki S; Emmert S; Pike KM; Raziuddin A; Plona TM; DiGiovanna JJ; Tucker MA; Kraemer KH
J Med Genet; 2011 Mar; 48(3):168-76. PubMed ID: 21097776
[TBL] [Abstract][Full Text] [Related]
5. Increased risk of internal tumors in DNA repair-deficient xeroderma pigmentosum patients: analysis of four international cohorts.
Nikolaev S; Yurchenko AA; Sarasin A
Orphanet J Rare Dis; 2022 Mar; 17(1):104. PubMed ID: 35246173
[TBL] [Abstract][Full Text] [Related]
6. Mutational spectrum of Xeroderma pigmentosum group A in Egyptian patients.
Amr K; Messaoud O; El Darouti M; Abdelhak S; El-Kamah G
Gene; 2014 Jan; 533(1):52-6. PubMed ID: 24135642
[TBL] [Abstract][Full Text] [Related]
7. Ocular manifestations of xeroderma pigmentosum: long-term follow-up highlights the role of DNA repair in protection from sun damage.
Brooks BP; Thompson AH; Bishop RJ; Clayton JA; Chan CC; Tsilou ET; Zein WM; Tamura D; Khan SG; Ueda T; Boyle J; Oh KS; Imoto K; Inui H; Moriwaki S; Emmert S; Iliff NT; Bradford P; Digiovanna JJ; Kraemer KH
Ophthalmology; 2013 Jul; 120(7):1324-36. PubMed ID: 23601806
[TBL] [Abstract][Full Text] [Related]
8. DNA repair protects against cutaneous and internal neoplasia: evidence from xeroderma pigmentosum.
Kraemer KH; Lee MM; Scotto J
Carcinogenesis; 1984 Apr; 5(4):511-4. PubMed ID: 6705149
[TBL] [Abstract][Full Text] [Related]
9. A prevalent mutation with founder effect in xeroderma pigmentosum group C from north Africa.
Soufir N; Ged C; Bourillon A; Austerlitz F; Chemin C; Stary A; Armier J; Pham D; Khadir K; Roume J; Hadj-Rabia S; Bouadjar B; Taieb A; de Verneuil H; Benchiki H; Grandchamp B; Sarasin A
J Invest Dermatol; 2010 Jun; 130(6):1537-42. PubMed ID: 20054342
[TBL] [Abstract][Full Text] [Related]
10. Clinical and genetic characteristics of xeroderma pigmentosum in Nepal.
Espi P; Parajuli S; Benfodda M; Lebre AS; Paudel U; Grange A; Grybek V; Grange T; Soufir N; Grange F
J Eur Acad Dermatol Venereol; 2018 May; 32(5):832-839. PubMed ID: 29178624
[TBL] [Abstract][Full Text] [Related]
11. Cockayne syndrome and xeroderma pigmentosum.
Rapin I; Lindenbaum Y; Dickson DW; Kraemer KH; Robbins JH
Neurology; 2000 Nov; 55(10):1442-9. PubMed ID: 11185579
[TBL] [Abstract][Full Text] [Related]
12. DNA repair and ultraviolet mutagenesis in cells from a new patient with xeroderma pigmentosum group G and cockayne syndrome resemble xeroderma pigmentosum cells.
Moriwaki S; Stefanini M; Lehmann AR; Hoeijmakers JH; Robbins JH; Rapin I; Botta E; Tanganelli B; Vermeulen W; Broughton BC; Kraemer KH
J Invest Dermatol; 1996 Oct; 107(4):647-53. PubMed ID: 8823375
[TBL] [Abstract][Full Text] [Related]
13. Xeroderma Pigmentosum: Part Two: Treatment of Skin Tumors with Topical Podophyllin 25% in Benzoin.
Sharquie K; Jabbar RI; Schwartz RA; Lambert MW; Lambert WC
Skinmed; 2023; 21(5):337-340. PubMed ID: 37945359
[TBL] [Abstract][Full Text] [Related]
14. The present status of xeroderma pigmentosum in Japan and a tentative severity classification scale.
Nakano E; Masaki T; Kanda F; Ono R; Takeuchi S; Moriwaki S; Nishigori C
Exp Dermatol; 2016 Aug; 25 Suppl 3():28-33. PubMed ID: 27539899
[TBL] [Abstract][Full Text] [Related]
15. Thyroid cancer in the thyroid nodules evaluated by ultrasonography and fine-needle aspiration cytology.
Lin JD; Chao TC; Huang BY; Chen ST; Chang HY; Hsueh C
Thyroid; 2005 Jul; 15(7):708-17. PubMed ID: 16053388
[TBL] [Abstract][Full Text] [Related]
16. Differences in peripheral neuropathy in xeroderma pigmentosum complementation groups A and D as evaluated by nerve conduction studies.
Lehky TJ; Sackstein P; Tamura D; Quezado M; Wu T; Khan SG; Patronas NJ; Wiggs E; Brewer CC; DiGiovanna JJ; Kraemer KH
BMC Neurol; 2021 Oct; 21(1):393. PubMed ID: 34627174
[TBL] [Abstract][Full Text] [Related]
17. Use of Big Data to Estimate Prevalence of Defective DNA Repair Variants in the US Population.
Pugh J; Khan SG; Tamura D; Goldstein AM; Landi MT; DiGiovanna JJ; Kraemer KH
JAMA Dermatol; 2019 Jan; 155(1):72-78. PubMed ID: 30516811
[TBL] [Abstract][Full Text] [Related]
18. Abnormal XPD-induced nuclear receptor transactivation in DNA repair disorders: trichothiodystrophy and xeroderma pigmentosum.
Zhou X; Khan SG; Tamura D; Ueda T; Boyle J; Compe E; Egly JM; DiGiovanna JJ; Kraemer KH
Eur J Hum Genet; 2013 Aug; 21(8):831-7. PubMed ID: 23232694
[TBL] [Abstract][Full Text] [Related]
19. [Ophtalmologic manifestations of the xeroderma pigmentosum].
Mseddi M; Sellami D; Elloumi Y; Aloulou Y; Kammoun B; Turki H; Feki J; Zahaf A
Tunis Med; 2006 Sep; 84(9):542-4. PubMed ID: 17263199
[TBL] [Abstract][Full Text] [Related]
20. Skin cancers in patients of skin phototype V or VI with xeroderma pigmentosum type C (XP-C): A retrospective study.
Ventéjou S; Bagny K; Waldmeyer J; Cartault F; Machet L; Osdoit S
Ann Dermatol Venereol; 2019 Mar; 146(3):192-203. PubMed ID: 30853323
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
